Reply to Xiaoshuai Gao, Guo Chen, and Xin Wei’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783–92

Checkpoint Inhibitors ◽

Meta Analysis ◽

Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol 2021;79:783–92

European Urology ◽

10.1016/j.eururo.2021.09.012 ◽

2021 ◽

Author(s):

Xiaoshuai Gao ◽

Guo Chen ◽

Xin Wei

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis

European Urology ◽

10.1016/j.eururo.2020.10.006 ◽

2020 ◽

Author(s):

Keiichiro Mori ◽

Mohammad Abufaraj ◽

Hadi Mostafaei ◽

Fahad Quhal ◽

Harun Fajkovic ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006

European Urology ◽

10.1016/j.eururo.2021.01.013 ◽

2021 ◽

Author(s):

Johanna Noel ◽

Olivier Huillard ◽

Francois Goldwasser

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser’s Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?

European Urology ◽

10.1016/j.eururo.2021.01.012 ◽

2021 ◽

Author(s):

Keiichiro Mori ◽

Manuela Schmidinger ◽

Shin Egawa ◽

Kilian M. Gust ◽

Shahrokh F. Shariat

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Clinical Activity ◽

First-Line Treatments for Advanced Renal-Cell Carcinoma with Immune Checkpoint Inhibitors: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis

SSRN Electronic Journal ◽

10.2139/ssrn.3391198 ◽

2019 ◽

Author(s):

Yongrui Bai ◽

Jie Fu ◽

Yuchen Liu ◽

Jiangyang Du ◽

Qiang Zhang ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cost Effectiveness ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

First Line ◽

Effectiveness Analysis

Complete response to immune checkpoint inhibitors-based therapy in advanced renal cell carcinoma patients. A meta-analysis of randomized clinical trials

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.06.021 ◽

2020 ◽

Vol 38 (10) ◽

pp. 798.e17-798.e24

Author(s):

R. Iacovelli ◽

C. Ciccarese ◽

F.A. Schutz ◽

G. Tortora ◽

G. de Velasco

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Randomized Clinical Trials ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Complete Response

The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2019.01161 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 21

Author(s):

Yongfeng Wu ◽

Jinming Xu ◽

Chengli Du ◽

Yihua Wu ◽

Dajing Xia ◽

...

Keyword(s):

Systematic Review ◽

Immune Checkpoint ◽

Predictive Value ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Tumor Mutation Burden ◽

Mutation Burden

Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review

Expert Review of Molecular Diagnostics ◽

10.1080/14737159.2019.1680286 ◽

2019 ◽

Vol 20 (2) ◽

pp. 169-185 ◽

Cited By ~ 5

Author(s):

Sara Elena Rebuzzi ◽

Fabiana Perrone ◽

Melissa Bersanelli ◽

Giacomo Bregni ◽

Michele Milella ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Molecular Biomarkers

BPI20-012: Relative Risk of Various Endocrinopathies Associated With the Use of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Renal Cell Carcinoma: a Systematic Review and Meta-Analysis

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2019.7448 ◽

2020 ◽

Vol 18 (3.5) ◽

pp. BPI20-012

Author(s):

Nusrat Jahan ◽

Francis Mogollon-Duffo ◽

Miguel Quirch ◽

Somedeb Ball ◽

Fred Hardwicke ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Relative Risk ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors

European Journal of Cancer ◽

10.1016/j.ejca.2020.06.008 ◽

2020 ◽

Vol 136 ◽

pp. 195-203 ◽

Cited By ~ 5

Author(s):

Roberto Iacovelli ◽

Chiara Ciccarese ◽

Emilio Bria ◽

Sergio Bracarda ◽

Camillo Porta ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Trials ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

First Line ◽

Sarcomatoid Renal Cell Carcinoma